Arch Iran Med. 2022;25(9): 591-599.
doi: 10.34172/aim.2022.94
PMID: 37543884
PMCID: PMC10685770
Scopus ID: 85144960326
  Abstract View: 1288
  PDF Download: 806

Original Article

Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; The Results of the STEPS of 2016

Saeid Shahraz 1 ORCID logo, Sahar Saeedi Moghaddam 2, Mehrdad Azmin 2, Niloofar Peykari 2,3, Moein Yoosefi 2, Farnam Mohebi 2,4, Shahab Khatibzadeh 5, Sahar Mohammadi Fateh 2,6, Shirin Djalalinia 2,7, Mitra Modirian 2, Negar Mahmoudi 2, Zohreh Mahmoudi 2, Sarina Dashti 2, Alireza Mahdavi Hezaveh 8, Bagher Larijani 6, Farshad Farzadfar 2,6* ORCID logo

1 Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
2 Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3 Deputy for Education, Ministry of Health and Medical Education, Tehran, Iran
4 Haas School of Business, University of California, Berkeley, CA 94720, USA
5 Brandeis University, Heller School for Social Policy and Management, Waltham, Massachusetts, USA
6 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
7 Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran
8 Center for Noncommunicable Disease Control and Prevention, Ministry of Health and Medical Education, Tehran, Iran
*Corresponding Author: Corresponding Author: Farshad Farzadfar, MD, MPH, MHS, DSC; Email: , Email: f-farzadfar@tums.ac.ir


Background: Using the WHO STEPwise approach to NCD risk factor surveillance (STEPS), first round of Iran’s STEPS completed in 2005. It has been repeated six times afterward. Here we report the results of 2016 round on the population characteristics and prevalence of diabetes and prediabetes, along with an assessment of the country-level performance on diabetes care in Iran.

Methods: Using a proportional-to-size cluster random sampling method, the STEPS 2016 included 18947 subjects aged≥25 years who matched the criteria (non-missing information on diabetes self-report, and biomarkers). For the analyses, survey design methods with weighted samples were employed. Different definitions of diabetes (biomarker-based, self-report, anti-diabetes medication use, or a combination) and prediabetes (different cutpoints of the biomarker) were calculated and presented.

Results: An estimated 5171035 persons aged≥25 years or 10.6% (95% CI: 10.0%–11.1%) had diabetes according to the serologic diagnosis of diabetes (FPG≥126 mg/dL) or the use of at least one anti-diabetes medication (1896 out of 18947). Employing the serologic diagnosis of diabetes among those who responded no to the self-reported question, 2.7% (2.5%–3.0%) of the population were not aware of their diabetes compared to 11.5% (10.9%-12.0%) who were diabetics according to the just self-reported question. Defining prediabetes as 100≤FPG<126 mg/dL or 5.7≤HbA1c<6.5%, an estimated 15244299 persons had prediabetes (5885 out of 18947). Overall, 52.1% (49.4%–54.7%) of patients with self-reported diabetes were under strict glycemic control (HbA1c<7%). Poor diabetes control (HbA1c>9%) was found in 18.4% (16.3%-20.6%) of the patients with self-reported diabetes.

Conclusion: Since 2005, the prevalence of diabetes in Iran has been on a gradual increase in both genders with an increasing gap between females and males.

Cite this article as: Shahraz S, Saeedi Moghaddam S, Azmin M, Peykari N, Yoosefi M, Mohebi F, et al. Prevalence of diabetes and prediabetes, and achievements in diabetes control in iran; the results of the steps of 2016. Arch Iran Med. 2022;25(9):591-599. doi: 10.34172/aim.2022.94
First Name
Last Name
Email Address
Security code

Abstract View: 1289

Your browser does not support the canvas element.

PDF Download: 806

Your browser does not support the canvas element.

Submitted: 23 Nov 2021
Revision: 09 Mar 2022
Accepted: 10 Apr 2022
ePublished: 01 Sep 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)